Literature DB >> 16326735

Calculation of glomerular filtration rate based on cystatin C in cirrhotic patients.

U Pöge1, T Gerhardt, B Stoffel-Wagner, H U Klehr, T Sauerbruch, R P Woitas.   

Abstract

BACKGROUND: Plasma creatinine and creatinine clearance are of limited value for the estimation of renal function in cirrhotics. In these patients, cystatin C (Cys C) has been proposed as an alternative marker of glomerular filtration rate (GFR) and Cys C-based equations for calculation of GFR have been developed in non-cirrhotic patient cohorts.
METHODS: We retrospectively analyzed correlation, bias, precision and accuracy of two Cys C-based formulae (Larsson and Hoek) for GFR estimation in comparison with two creatinine-based equations (Cockroft & Gault and MDRD). The Cys C was determined by an immunonephelometric method. The GFR was measured by means of inulin clearance in 44 consecutive patients with liver cirrhosis.
RESULTS: On average, inulin clearance was 28.3 (95% CI: 29.2-41.3 ml/min/1.73 m2). Creatinine as well as Cys C-based equations overestimated the true GFR by 105-154%. However, Cys C-based equations showed significantly lower bias and higher precision than the creatinine-based formulae. Correlation and accuracy tended to be better with the Hoek and Larsson equation than with the Cockroft & Gault or MDRD formulae. Hoek and Larsson equations showed a similar diagnostic performance in all statistical procedures.
CONCLUSION: Our data suggest a significant improvement of GFR estimation in liver cirrhotics by means of the Cys C-based Hoek and Larsson formulae. However, all estimates remain a crude approximation of true GFR and thus cannot replace gold standard methods.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16326735     DOI: 10.1093/ndt/gfi305

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  34 in total

Review 1.  Kidney Failure and Liver Allocation: Current Practices and Potential Improvements.

Authors:  Varun Saxena; Jennifer C Lai
Journal:  Adv Chronic Kidney Dis       Date:  2015-09       Impact factor: 3.620

Review 2.  GFR Estimating Equations and Liver Disease.

Authors:  Tomasz Beben; Dena E Rifkin
Journal:  Adv Chronic Kidney Dis       Date:  2015-09       Impact factor: 3.620

Review 3.  Biomarkers in chronic kidney disease, from kidney function to kidney damage.

Authors:  Salvador Lopez-Giacoman; Magdalena Madero
Journal:  World J Nephrol       Date:  2015-02-06

4.  Gender disparity in liver transplant waiting-list mortality: the importance of kidney function.

Authors:  Ayse L Mindikoglu; Arie Regev; Stephen L Seliger; Laurence S Magder
Journal:  Liver Transpl       Date:  2010-10       Impact factor: 5.799

5.  Cystatin C is a moderate predictor of acute kidney injury in the early stage of traumatic hemorrhagic shock.

Authors:  Shu Chen; Jing-Song Shi; Xiaokaiti Yibulayin; Tian-Shan Wu; Xin-Wen Yang; Jie Zhang; Paerhati Baiheti
Journal:  Exp Ther Med       Date:  2015-04-23       Impact factor: 2.447

6.  Evaluation of Vancomycin Dosing in Patients With Cirrhosis: Beginning De-Liver-ations about a New Nomogram.

Authors:  Randolph E Regal; Steven P Ren; Gregory Paige; Cesar Alaniz
Journal:  Hosp Pharm       Date:  2018-04-26

Review 7.  Acute kidney injury in patients with cirrhosis: perils and promise.

Authors:  Justin M Belcher; Chirag R Parikh; Guadalupe Garcia-Tsao
Journal:  Clin Gastroenterol Hepatol       Date:  2013-04-10       Impact factor: 11.382

8.  Cystatin C level as a marker of kidney function in human immunodeficiency virus infection: the FRAM study.

Authors:  Michelle C Odden; Rebecca Scherzer; Peter Bacchetti; Lynda Anne Szczech; Stephen Sidney; Carl Grunfeld; Michael G Shlipak
Journal:  Arch Intern Med       Date:  2007-11-12

Review 9.  Renal dysfunction in chronic liver disease.

Authors:  Andy Slack; Andrew Yeoman; Julia Wendon
Journal:  Crit Care       Date:  2010-03-09       Impact factor: 9.097

10.  Cystatin C--a paradigm of evidence based laboratory medicine.

Authors:  Janice S C Chew; Mohammed Saleem; Christopher M Florkowski; Peter M George
Journal:  Clin Biochem Rev       Date:  2008-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.